Finland will donate diesel locomotives to Ukraine’s state railway, the Office of Ukraine’s President reported. Helsinki also pledged new winter aid, and the two countries signed deals on drones, housing, and satellite communications during Finnish Prime Minister Petteri Orpo’s visit to Kyiv. One of them is a first step toward a satellite link Ukraine would control itself.

With Russia replacing its missiles as fast as it fires them, Ukraine heads into winter needing equipment that works without the grid. Russian strikes have damaged or destroyed almost 600 locomotives of Ukraine’s state railway since the full-scale invasion began, more than 300 of them diesels, the infrastructure minister said. The attacks have reached engines even near the Polish border, on the railway that carries Ukraine’s evacuations, grain, and cargo.

Diesels that keep moving when the grid goes down

Finland will hand 10 locomotives and their spare parts to Ukrzaliznytsia, Ukraine’s state railway, free of charge. Infrastructure Minister Mykola Kalashnyk announced the deal, signed on 22 October at a Ukrainian-Finnish business forum. The engines need no power from overhead lines, so trains can keep running during blackouts.

The engines are Dv12 diesels that VR, Finland’s state rail company, is taking out of service. A VR shareholders’ meeting moved them into state ownership, and the Finnish state is donating them, Yle reported. VR puts their value, spare parts included, at about €2.1 million. Finland’s government said the gift will not affect VR’s ability to run trains at home.

Ukrainian Prime Minister Serhii Koretskyi and Orpo signed the donation certificate, one of seven documents signed that day. Two others plan Ukrainian-Finnish drone production in Finland, one for military and dual-use systems and one for heavy drones. Another covers a precast concrete plant for industrial housing construction.

The day’s agreements are worth around €300 million in total, Zelenskyy said. Projects worth €200 million are already under way within the two countries’ Drone Deal, he added. Under an earlier plan, most drones made in Finland would go to Ukraine.

Winter money now, a 36th military package by year’s end

Orpo announced a new €10 million package. Of it, €5 million goes to the Ukraine Energy Support Fund and €2 million to humanitarian aid for winter. The last €3 million goes to the Ukraine Recovery Program, for energy and water supply. Finland will also deliver mobile heating containers by December.

Finland has given Ukraine five defense packages this year, worth more than €500 million combined, Militarnyi reported. A 36th package is being prepared together with Ukraine’s military. “We plan to make a decision by the end of this year,” Orpo said. In September, Finland approved a package worth about €290 million.

A satellite link Ukraine would own

Ukraine’s Defense Ministry signed a letter of intent with Finnish satellite firm ICEYE and telecom company Nokia, Militarnyi reported, citing ICEYE. The parties will explore building a secure satellite communications system under Ukraine’s control. The aim is to reduce Ukraine’s dependence on foreign commercial operators.

In this model, the state customer owns the satellites, ground stations, and user terminals, RBC-Ukraine reported. The network could serve defense, border protection, emergency services, and disaster recovery. The letter sets out no timeline or funding.

“Modern warfare has proven that reliable communications are a matter of national security,” Zelenskyy said in the companies’ statement. ICEYE CEO Rafal Modrzewski said Ukraine needs “secure, sovereign and high-performance satellite communications systems that it controls.”

The deal comes after a speed cap on Starlink disrupted Ukrainian drone missions this month. The EU, meanwhile, is pushing three European firms to merge into one SpaceX rival. ICEYE has supplied Ukraine with radar satellite imagery for years.

Days before the signing, tracking firm LeoLabs said a Russian government-owned satellite, Cosmos 2612, had spent weeks shadowing an ICEYE radar satellite, coming within 500 meters. The ICEYE satellite is widely believed to provide imagery to Ukraine.

Neither fix is quick. Ukraine’s big locomotive order arrives from 2027, and the first satellites of the ICEYE-Nokia system are expected to launch only in 2028.

Health workers, activists, and access to medicines advocates have gathered in Frankfurt on October 22-23 for the 2nd Public Pharma Conference. The event builds on roughly two years of work by the Public Pharma for Europe Coalition, which aims to construct an alternative vision for the region’s pharmaceutical landscape – and to strengthen the links needed to turn that vision into reality.

“When we had the first conference in 2024, we realized there are many people practically working on this topic who shared a similar vision and a similar goal,” Frauke Heller from medico international told BreakThrough News. 

The new conference aims to open the space to even more advocates, she added, in a region where the Big Pharma lobby remains extremely influential.

Read more: Public pharma infrastructure could give the world access to a treasure trove of medicines

The first day focused on the coalition’s expansion and the shifting global landscape it faces, including growing concerns about the availability and affordability of medicines across Europe. 

Speakers – including commons activist Gaëlle Krikorian, Tim Joye, president of Medics for the People (MPLP-GVHV), researcher Tineke Kleinhout-Vliek, and Jan Wintgens, coordinator of the People’s Health Movement (PHM) Public Pharma program in Europe – detailed how a system reliant on Big Pharma is deepening these access problems.

Their interventions also highlighted that alternatives already exist. Kleinhout-Vliek pointed to dozens of existing examples of drug research, development, and innovation projects in Europe alone that are supported by the public sector in different ways. “This used to happen only in ‘market-failure’ areas, but it’s now moving into profitable drugs too,” she pointed out.

Austerity is exacerbating access to medicines issues

The conference recognized that rising drug prices in Europe have sharpened the visibility of this issue compared to earlier years, when social security systems were still able to secure access to medicines for patients in the region. That is less the case today, as Big Pharma companies set exorbitant prices for new products – and social security systems themselves are undermined by austerity.

The effects are felt across the region, with Joye and Krikorian turning to examples from Belgium and France. In Belgium, Joye said, the case of a family forced to fundraise close to €2 million for a spinal muscular atrophy injection for a baby reinforced MPLP’s efforts to envision a different pharma system. In France, current drug prices have been driving both patients and pharmacists “out of their minds,” Krikorian emphasized, prompting them to become more critical of the whole system.

Read more: Listening through the social stethoscope: MPLP’s health workers redefine care in Belgium

These developments cannot be separated from the situation affecting the world today, related to the weakening position of the United States, speakers and participants seemed to agree.

“If we compare the world in March 2024 to today, the difference is enormous,” Joye said, citing a recent decision by drug giant GSK to cut 1,200 jobs from its 8,000-strong operations in Belgium. “This is not a company in financial difficulties: they’re cutting jobs because they’re planning to shift part of their operations to the US under the influence of the Trump administration.”

People in Europe are growing increasingly scared of war, due to their governments’ arms race, he added, but also of losing their jobs. “Politicians using this fear to increase the power of the multinationals instead of changing the system.”

Experiences from socialism and the Global South

As the European Public Pharma coalition continues to grow its ranks, it remains attentive to experiences from the past, including the public production of vaccines in formerly socialist states of Eastern Europe – as presented by David Franco from Public Pharma for Europe and Goran Jeras from the Cooperative for Ethical Financing.

But the platform is also looking toward practical examples of orienting pharmaceutical research and production away from a profit-making model. This includes the work of Cuban scientists, who have achieved groundbreaking breakthroughs despite the ongoing blockade imposed by the US, as well as medical research institutes in Brazil and efforts to establish public production of therapies in Canada.

Gerardo Guillén from the China-Cuba Biotechnology Innovation Center linked the island’s breakthroughs – including interferon therapy, innovative treatments for diabetic foot, and COVID-19 medicines – to the people-centered healthcare erected following the revolution. 

Cuba’s persistent research and innovation cannot be separated from Fidel Castro‘s appeal for a science-based revolution – a science that serves the needs of the people – Guillén pointed out.

Read more: Humanity owes Cuba: unilateral coercive measures and the politics of punishment

Another example came from Martin Häuer of the Open Source Imaging Initiative (OSI²), who walked participants through existing efforts to build MR imaging machines using open-source tools. For now, the project team was able to assemble functioning prototypes for around €20,000 – with reassembly in low-income health systems like Ghana’s projected at around €24,000.

This amount represents roughly 10% of the standard market price of an MRI: significantly increasing the chance of the technology becoming more widely accessible and showing how significant the impact of these initiatives can be globally.

People’s Health Dispatch is a monthly bulletin published by the People’s Health Movement and Peoples Dispatch. For more articles and to subscribe to People’s Health Dispatch, click here.